Drug Shortage Report for MYLAN-ATORVASTATIN
| Report ID | 19456 |
| Drug Identification Number | 02392976 |
| Brand name | MYLAN-ATORVASTATIN |
| Common or Proper name | ATORVASTATIN |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATORVASTATIN |
| Strength(s) | 80MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 90BT, 500BT |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-10-20 |
| Actual start date | |
| Estimated end date | 2018-10-26 |
| Actual end date | 2018-10-23 |
| Shortage status | Resolved |
| Updated date | 2018-10-24 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v38 | 2018-09-01 | English | Compare |
| v37 | 2018-08-30 | French | Compare |
| v36 | 2018-08-30 | English | Compare |
| v35 | 2018-08-30 | English | Compare |
| v34 | 2018-08-30 | English | Compare |
| v33 | 2018-08-28 | French | Compare |
| v32 | 2018-08-28 | English | Compare |
| v31 | 2018-08-27 | French | Compare |
| v30 | 2018-08-27 | English | Compare |
| v29 | 2018-08-24 | English | Compare |
| v28 | 2018-08-23 | French | Compare |
| v27 | 2018-08-23 | English | Compare |
| v26 | 2018-08-23 | English | Compare |
| v25 | 2018-08-21 | French | Compare |
| v24 | 2018-08-21 | English | Compare |
| v23 | 2018-08-21 | French | Compare |
| v22 | 2018-08-21 | English | Compare |
| v21 | 2018-08-16 | English | Compare |
| v20 | 2018-08-15 | French | Compare |
| v19 | 2018-08-15 | English | Compare |